These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6773242)

  • 41. [State of post-transfusion hepatitis in the National Utano Sanatorium with special reference to the comparison of blood from paid donors and volunteer donors].
    Ichitani M; Kusama I; Yoshida N; Kurata M; Kai T
    Naika; 1968 Mar; 21(3):549-52. PubMed ID: 5685637
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diagnostic significance of an aspartate aminotransferase screening test of blood donors for preventing posttransfusion hepatitis].
    Pobedinskaia IN; Burlev VA; Golosova TV
    Probl Gematol Pereliv Krovi; 1981 Mar; 26(3):42-5. PubMed ID: 7232379
    [No Abstract]   [Full Text] [Related]  

  • 43. [Au-SH-antigen and blood transfusion].
    Fröhlich C
    Hippokrates; 1971 Mar; 42(1):118-20. PubMed ID: 5550575
    [No Abstract]   [Full Text] [Related]  

  • 44. [Viral hepatitis B].
    Reesink HW
    Tijdschr Ziekenverpl; 1976 Mar; 29(5):221-8. PubMed ID: 1045677
    [No Abstract]   [Full Text] [Related]  

  • 45. Plasma fractionation in England and Wales.
    Vallet L
    Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
    [No Abstract]   [Full Text] [Related]  

  • 46. [Blood transfusion proportionally and moderately].
    Reissigl H
    Z Allgemeinmed; 1974 Mar; 50(7):321-4. PubMed ID: 4848151
    [No Abstract]   [Full Text] [Related]  

  • 47. [The costs of blood and blood substitutes].
    Gullbring B
    Lakartidningen; 1972 Dec; 69():Suppl 4:92-4. PubMed ID: 4656854
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevention of transfusion-transmitted hepatitis.
    Sacher RA; Schreiber GB; Kleinman SH
    Lancet; 2000 Jan; 355(9201):331-2. PubMed ID: 10665547
    [No Abstract]   [Full Text] [Related]  

  • 49. [Study of blood transaminases in blood donors in the prevention of post-transfusion virus hepatitis].
    Teofili T; Tucci G
    Ann Med Nav (Roma); 1969; 74(1):31-43 contd. PubMed ID: 5405058
    [No Abstract]   [Full Text] [Related]  

  • 50. Transfusion-transmitted viral hepatitis.
    Mosley JW
    Clin Lab Med; 1982 Mar; 2(1):233-52. PubMed ID: 7186430
    [No Abstract]   [Full Text] [Related]  

  • 51. [The importance of gamma-glutamyltranspeptidase screening to the prevention of post-transfusion hepatitis (author's transl)].
    Nedvĕd J; Hudec J
    Cas Lek Cesk; 1978 Feb; 117(5):137-9. PubMed ID: 24497
    [No Abstract]   [Full Text] [Related]  

  • 52. Hazards of blood and blood products. Case report of post-transfusion hepatitis-B.
    Wirtz CE; Kirchner JP; Maloney PM
    Wis Med J; 1985 May; 84(5):10-1. PubMed ID: 4013365
    [No Abstract]   [Full Text] [Related]  

  • 53. [Attempted detection and prevention of post-transfusional viral hepatitis].
    Heusghem C
    Bull Acad R Med Belg; 1970; 11(10):601-34. PubMed ID: 5514807
    [No Abstract]   [Full Text] [Related]  

  • 54. Preparation of lyophilized heat-treated cryoprecipitates from a small pool of plasma obtained by apheresis.
    Allersma DP; Roeffen E; Van der Does JA; Briët E
    Pharm Weekbl Sci; 1991 Feb; 13(1):18-23. PubMed ID: 1903526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-transfusion hepatitis.
    Br Med J; 1967 Feb; 1(5535):256. PubMed ID: 6017473
    [No Abstract]   [Full Text] [Related]  

  • 56. [Examination of a Swedish group of blood donors and a group of patients with hepatitis by means of the hepatitis infectious mononucleosis (HIM) test].
    Iwarson S; Rawling O
    Nord Med; 1968 Aug; 80(31):1016-9. PubMed ID: 5698776
    [No Abstract]   [Full Text] [Related]  

  • 57. The physiologic basis of the use of blood and blood products.
    Gould SA; Rice CL; Moss GS
    Surg Annu; 1984; 16():13-38. PubMed ID: 6427954
    [No Abstract]   [Full Text] [Related]  

  • 58. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 59. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening.
    Allain JP
    Vox Sang; 2007 Apr; 92(3):254-7. PubMed ID: 17348876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Post-transfusion hepatitis].
    Heidel G
    Z Gesamte Hyg; 1969 Mar; 15(3):189-96. PubMed ID: 5372982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.